Interventional Radiology Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Interventional Radiology Market Trends & Drivers

Growing Demand for Minimally Invasive Procedures Is Key Trend

• The paradigm shift toward minimally invasive medical interventions significantly propels the interventional radiology market growth.
• Patients increasingly prefer procedures offering reduced pain, shorter hospital stays, and faster recovery times compared to traditional open surgery.
• By 2030, 1 in 6 people in the world will be aged 60 years or over.
• This demographic transformation particularly benefits from minimally invasive approaches, as elderly patients often present with multiple comorbidities that increase surgical risks.
• Interventional radiology procedures offer viable treatment options for this vulnerable population, enabling effective management of complex conditions with reduced perioperative morbidity.
• Healthcare economic pressures further accelerate the adoption of minimally invasive techniques.
• Additionally, the ability to perform many interventional procedures in outpatient settings enhances healthcare accessibility while optimizing facility utilization.
• Advanced AI algorithms are increasingly being integrated into imaging systems to assist in planning, navigation, and real-time decision-making during interventional procedures.
• For example, AI-enabled CT and MRI platforms can automatically detect lesions or vascular blockages, thus reducing procedure time and improving accuracy.
• Robotic systems for angioplasty, stent placement, and tumor ablation allow for enhanced precision, minimizing human error and improving outcomes.

Rising Prevalence of Chronic Diseases Is Biggest Driver

• The global surge in chronic disease prevalence constitutes the primary growth driver for the interventional radiology market.
• Cardiovascular diseases account for at least 19 million deaths each year, followed by cancers with 10 million, chronic respiratory diseases with 4 million, and diabetes over 2 million, including kidney disease deaths caused by diabetes.
• According to the World Health Organization, chronic diseases account for 71% of all deaths globally, with cardiovascular diseases alone responsible for 17.9 million deaths annually.
• This escalating disease burden creates substantial demand for interventional radiology procedures across multiple clinical applications.
• The correlation between chronic disease prevalence and interventional radiology utilization is particularly evident in cardiovascular interventions.
• An estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths.
• Of these deaths, 85% were due to heart attack and stroke. These statistics underscore the critical role of interventional procedures such as angioplasty, stenting, and embolization in managing cardiovascular conditions.
• The rising incidence drives demand for advanced imaging systems and interventional devices, as healthcare providers seek efficient solutions for treating complex vascular pathologies.
• Furthermore, the cancer burden significantly contributes to market growth through increased demand for interventional oncology procedures.
• Techniques including tumor ablation, chemoembolization, and radioembolization provide minimally invasive alternatives to surgical resection, particularly beneficial for patients with inoperable tumors or those unable to tolerate conventional surgery.
• The expanding applications of interventional radiology in cancer management, coupled with improving clinical outcomes, position this specialty as an integral component of comprehensive cancer care.

Interventional Radiology Market Segmentation Analysis

Product Type Analysis

The MRI systems category held the largest market share in 2024, and it will have the highest CAGR, due to the advancements in technologies and the surgical demand for MRI systems. It captures images using a magnetic field and radiofrequency, producing clear and detailed visuals of soft tissues. This growth trajectory reflects increasing adoption of MRI-guided interventions, particularly in oncology and neurology applications. The superior soft tissue contrast and absence of ionizing radiation position MRI as an attractive imaging modality for specific interventional procedures. Technological advances in real-time MRI imaging, temperature monitoring capabilities for thermal ablation procedures, and development of MRI-compatible interventional devices expand the clinical utility of these systems. The growing emphasis on radiation-free interventional approaches, particularly for pediatric and reproductive-age patients, further accelerates MRI system adoption in interventional radiology practice.

The product types analyzed in this report are:

• Angiography Systems
• MRI Systems (Largest and Fastest-Growing Category)
• CT Systems
• Ultrasound Systems

Procedure Type Analysis

The angioplasty category held the largest market share, of about 35%, in 2024, owing to the increasing number of cardiovascular diseases. The widespread prevalence of coronary artery disease, peripheral arterial disease, and cerebrovascular conditions drives consistent demand for angioplasty procedures. Technological refinements in balloon catheter design, drug-eluting technologies, and imaging guidance systems enhance procedural success rates and long-term patency, reinforcing angioplasty's position as a primary interventional treatment modality.

The embolization category will have the highest CAGR, of 6.1%, ascribed to the expanding clinical applications, including treatment of hemorrhage, vascular malformations, and tumor devascularization. The development of advanced embolic agents, including drug-eluting beads and radioembolization microspheres, broadens therapeutic possibilities in interventional oncology. Growing recognition of embolization's effectiveness in managing benign conditions, such as uterine fibroids and benign prostatic hyperplasia, further diversifies procedural applications and drives market expansion.

The procedure types analyzed in this report are:

• Angioplasty (Largest Category)
• Biopsy and Drainage
• Embolization (Fastest-Growing Category)
• Catheter-Directed Thrombolysis
• Vertebroplasty
• Nephrostomy

Application Analysis

The cardiology category held the largest market share, of about 40%, in 2024, driven by the substantial global burden of cardiovascular diseases and the established role of interventional techniques in cardiac care. The comprehensive range of cardiac interventions, including coronary angioplasty, structural heart procedures, and electrophysiology interventions, generates consistent procedural volumes. Advanced imaging integration, including intravascular ultrasound and optical coherence tomography, enhances procedural precision and clinical outcomes in cardiac interventions.

The oncology category will have the highest CAGR, due to the paradigm shift towards minimally invasive cancer treatments and the expanding role of interventional radiology in comprehensive cancer care. Interventional oncology procedures, including tumor ablation, transarterial chemoembolization, and radioembolization, offer therapeutic options for patients with unresectable tumors or those unsuitable for surgery. The development of combination therapies integrating interventional techniques with systemic treatments and immunotherapy creates synergistic treatment approaches, driving increased utilization of interventional radiology in oncology practice.

The applications analyzed in this report are:

• Cardiology (Largest Category)
• Oncology (Fastest-Growing Category)
• Urology and Nephrology
• Gastroenterology
• Obstetrics and Gynecology

End User Analysis

The hospitals category held the larger market share in 2024, due to the availability of expert healthcare professionals and a widespread patient count in these healthcare facilities. As the population grows, the demand for cancer screening and imaging rises, leading to higher diagnosis rates and treatment volumes. Thus, this factor helps the industry to expand. Furthermore, hospitals attend a large influx of in-patients with coronary heart disease, atherosclerosis, and general surgeries than ambulatory surgical centers (ACSs), due to which they gather large funds that assist in installing advanced radiology instruments.

Moreover, hospitals that are active in conducting R&D have great resources and utilization of instruments, which serve for the betterment of society, hence patients. They also help government and non-government units by promoting awareness about chronic diseases and their diagnosis through radiology.

The ambulatory surgical centers category will have the higher CAGR. This growth trajectory reflects the ongoing shift towards outpatient care delivery and the economic advantages of performing appropriate procedures in lower-cost settings. Technological advances enabling safer outpatient interventions, improved patient selection criteria, and favorable reimbursement policies for ASC-based procedures drive this transition. The development of dedicated interventional radiology ASCs, offering specialized expertise and streamlined workflows, enhances efficiency while maintaining high-quality outcomes for selected patient populations.

The end users analyzed in this report are:

• Hospitals (Larger Category)
• Ambulatory Surgical Centers (Faster-Growing Category)

Interventional Radiology Market Geographical Analysis

North America Interventional Radiology Market Size

North America held the largest market share, of around 40%, in 2024, due to the increasing cases of chronic illnesses, the growing geriatric population, the availability of minimally invasive methods, the high disposable income of people, the well-established healthcare infrastructure, advancements in technologies, and the development of new products in the region.

U.S. Interventional Radiology Market Size

The U.S. dominates in North America, supported by extensive hospital networks, specialized interventional radiology centers, and robust clinical research activities. The high burden of cardiovascular diseases and cancer in North America sustains demand for interventional procedures. The combination of high disease prevalence, an aging population, and rising obesity rates continues to drive steady growth in procedural volumes. Advanced technology adoption, including AI-integrated imaging systems, robotic-assisted interventions, and hybrid operating suites, positions North American facilities at the forefront of interventional radiology innovation.

Asia-Pacific Interventional Radiology Market Size

Asia-Pacific will have the highest CAGR. This can be ascribed to the surging progression in healthcare infrastructure, the rising medical tourism sector, the growing geriatric population, and the dedication of medical professionals in terms of learning and upskilling themselves in the region. In addition, the most common interventional radiological procedure is cerebral angiography in China, followed by percutaneous transhepatic cholangiography, cerebral aneurysm interventions, percutaneous transluminal angioplasty, and transcatheter arterial chemoembolization. Additionally, developing countries, rural areas, and underdeveloped healthcare facilities provide immense opportunities to investors/players in the APAC interventional radiology sector.

The region's vast population base, coupled with rapid economic development and healthcare modernization initiatives, creates substantial growth opportunities for interventional radiology technologies and services. Japan's mature market continues to innovate, particularly in advanced imaging technologies and robot-assisted interventions, while maintaining high procedural standards and clinical outcomes.

China Interventional Radiology Market Size

China leads regional growth, supported by government healthcare reforms, hospital infrastructure expansion, and increasing adoption of advanced medical technologies. The country's focus on improving healthcare accessibility in tier-2 and tier-3 cities drives demand for interventional radiology equipment and training programs. India demonstrates exceptional growth potential, with expanding private healthcare sectors, medical tourism initiatives, and rising awareness of minimally invasive treatment options.

Europe Interventional Radiology Market Size

Europe has constant growth due to well-established healthcare systems, comprehensive insurance coverage, and strong clinical expertise in interventional radiology. The region benefits from harmonized medical device regulations, facilitating market access across European Union member states, while maintaining high safety and efficacy standards. Germany leads the regional market, supported by advanced hospital infrastructure, robust reimbursement systems, and strong medical device manufacturing capabilities.

The U.K. and France represent significant markets within Europe, each demonstrating steady growth driven by aging populations and increasing chronic disease burden. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). This demographic shift particularly impacts European countries with established aging populations, driving demand for interventional procedures suitable for elderly patients. The region's focus on value-based healthcare and cost-effectiveness encourages the use of minimally invasive procedures, reducing hospital stays and optimizing resource use.

The geographical breakdown of the market is as follows:

• North America (Largest Regional Market)
  • U.S. (Larger Country)
  • Canada (Faster-Growing Country)
• Europe
  • Germany (Largest Country)
  • U.K. (Fastest-Growing Country)
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (Fastest-Growing Regional Market)
  • China (Largest Country)
  • India (Fastest-Growing Country)
  • Japan
  • South Korea
  • Australia
  • Rest of APAC
• Latin America
  • Brazil (Largest Country)
  • Mexico (Fastest-Growing Country)
  • Rest of LATAM
• Middle East and Africa
  • Saudi Arabia (Fastest-Growing Country)
  • South Africa
  • U.A.E. (Largest Country)
  • Rest of MEA

Interventional Radiology Market Share

The market is semi-consolidated due to the presence of a few dominant players alongside numerous smaller companies. Major companies like Siemens Healthineers, GE Healthcare, Philips, and Canon Medical hold significant market shares due to their advanced product portfolios and global reach. However, several mid-sized and regional players continue to operate actively, providing niche or cost-effective solutions. Additionally, this mix of strong global leaders and smaller competitors shapes the market, driving both innovation and competitive pricing across different regions.

Interventional Radiology Market News

• In June 2025, Koninklijke Philips N.V. and Methodist Hospitals declared the healthcare provider's strategic investment in Philips' sophisticated range of image-guided therapy solutions, which combine imaging systems and software with specialized diagnostic and therapeutic devices. The newly established interventional suites will address essential health requirements within the community, encompassing active stroke treatment, oncology therapies, complex cardiovascular interventions, and care for other common health issues.
• In March 2025, Gleneagles Hospital Bengaluru introduced its cutting-edge Advanced Interventional Radiology Cath Lab at its Richmond Road location, further solidifying its dedication to innovative, minimally invasive therapies. Furnished with the most advanced image-guided technology, this sophisticated Cath Lab will facilitate precision-focused vascular and non-vascular interventions, intricate tumour ablations, embolization techniques, and high-quality diagnostic imaging.
• In June 2024, GE HealthCare Technologies Inc. and MediView XR Inc. announced the world's first installation of the OmnifyXR augmented reality interventional suite at North Star Vascular and Interventional in Minneapolis, combining holographic visualization with live imaging to transform interventional radiology practice.
• In March 2023, Koninklijke Philips N.V. launched an integrated interventional platform combining advanced imaging, device guidance, and clinical decision support tools to optimize procedural workflows and patient outcomes.